NEWS

MicroVention Announces Positive Safety and Effectiveness Results in WEB-...

The WEB-IT pivotal trial highlights positive clinical outcomes with the WEB® Aneurysm Embolization System, the only intrasaccular flow disruptor approved in the United States.

Stent-assisted coiling

"There needs to be active dialogue with physicians to discuss […] what t...

Pascal Girin, CEO of BALT, shares how his rich career in neurovascular medical technology helped him to transform the company from a small R&D pure player into an international market leader. Girin goes on to explain the high key growth strategy he is implementing and the impact that BALT’s products can have on the quickly developing medical field of stroke treatment.

Vesalio Reports Expansion of International Distributor Network and Strok...

Nashville, TN, April 02, 2019 --(PR.com)-- Vesalio announces it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market coverage in 39 countries for the NeVa™ Neuro-thrombectomy System.

Treatment of a big basilar artery

INR approaches to stroke and aneurysms

Balt International has announced receiving the CE mark for the Ballast ....

Balt International has announced receiving the CE mark for the Ballast .088 Long Sheath. The Ballast .088 Long sheath is indicated for the introduction of interventional devices into peripheral, coronary and neurovasculature. It is a class III medical device which is described as a guiding catheter and as an introducer sheath.The Ballast .088 will be commercially available in different lengths, from 80 cm, via 90 cm and up to a 100 cm long.This new generation sheath is designed with a braided reinforced proximal segment, an optimised progressively softer distal coil segment and a low-profile outer diameter to deliver the right balance between atraumatic navigation and proximal support.With this new Ballast .088 Long sheath, Balt International offers its premium sheath, designed to improve support and navigationPascal Girin, Balt International’s CEO stated, "The clearance of the Ballast .088 Long Sheath is a significant milestone in our global commercialisation efforts and a major step towards delivering a complete portfolio of innovative solutions"."The Ballast .088 Long Sheath represents an advance in technology for physicians around the world. It also is a fantastic representation of the capabilities of the new global Balt, with full R&D teams in both France and the USA developing physician inspired technologies to advance the care of patients with neurovascular diseases" commented Dave Ferrera, Senior VP of Global R&D and CTO of Balt USA.

AVMs, aneurysms and more

Right MCA aneurysm

Bilateral sigmoid sinuses stenosis